Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Strawberries could mitigate colonic inflammation

Inflammatory bowel disease is a set of painful conditions that can cause severe diarrhea and fatigue. Treatments can include medications and surgery. But now researchers report that a simple dietary intervention could mitigate colonic inflammation and improve gut health.

20 Aug 2018

Understanding How Antibodies Shape the Gut Microbiome

Dr. Keiichiro Suzuki discusses the importance of IgA in the human body, and his recent research study, which showed that IgA interacts with the gut microbiome and promotes the growth of healthy bacteria.

20 Aug 2018

Researchers discover new protein that controls level of inflammation-inducing molecule

One of the major therapeutic targets for inflammatory diseases is the inflammation-inducing molecule TNF. However, excess levels of TNF cause side effects and can lead to diseases.

27 Jul 2018

Long-lasting HIV control without antiretroviral therapy is a feasible goal, says expert

Long-lasting control of HIV infection without antiretroviral therapy is a feasible goal that deserves vigorous pursuit, Anthony S. Fauci, M.D., will assert during a lecture on Wednesday, July 25 at the 22nd International AIDS Conference in Amsterdam.

26 Jul 2018

Scientists find key link between viruses and inflammatory bowel diseases

A study led by a researcher at the University of Colorado Anschutz Medical Campus reveals a key connection between viruses and inflammatory bowel diseases like ulcerative colitis and Crohn's disease.

23 Jul 2018

Study demonstrates new therapeutic targets for inflammation-associated colon cancer

Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine (IRB Barcelona) report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets. The study has been published in the journal EMBO Molecular Medicine.

12 Jul 2018

Scientists pinpoint new therapeutic targets for inflammation-associated colon cancer

Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets

11 Jul 2018

Study offers new hope for people with disabling Dupuytren's disease

Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians at NHS Lothian, have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for progression of Dupuytren's disease.

9 Jul 2018

Key innovations awards recognize PENTAX Medical for new product developments

PENTAX Medical is pleased to announce that the innovation within its new product developments has been recognized by two key awards.

From PENTAX Medical Company 6 Jul 2018

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

In preclinical experiments, Laurie Harrington, Ph.D., and colleagues at the University of Alabama at Birmingham have discovered a subset of immune cells that create and sustain chronic inflammatory bowel disease.

27 Jun 2018

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis every year in the United States, affecting 2.2% of the population.

20 Jun 2018

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Microbiotica, a leading player in microbiome-based therapeutics, today announced that it has entered into an agreement with University of Adelaide as part of its program to develop a defined bacterial product for ulcerative colitis (UC). Financial details have not been disclosed.

19 Jun 2018

Faeces donors do it out of willingness not money - study

Healthy adults who have a good constitution and have a healthy heart are being called forth to donate samples of their faeces to science. The donors would be screened rigorously before they can be included and would be compensated modestly for their donations say researchers.

6 Jun 2018

Cedars-Sinai study identifies gut gas associated with diarrhea

Cedars-Sinai investigators have for the first time identified a gas produced in gut that could improve the diagnosis and treatment of patients with two common intestinal illnesses - small intestine bacterial overgrowth and irritable bowel syndrome.

6 Jun 2018

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

A novel positron emission tomography imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease, which includes ulcerative colitis and Crohn's disease.

4 Jun 2018

Study: People taking immunosuppressant drugs less likely to develop Parkinson's disease

People who take drugs that suppress the immune system are less likely to develop Parkinson's disease, according to a study from Washington University School of Medicine in St. Louis.

31 May 2018

Researchers trigger natural defense mechanism to alleviate intestinal inflammation

Treating inflammatory diseases of the bowel is extremely challenging: Genes, gut microbes and disrupted immune function all contribute.

31 May 2018

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

The U.S. Food and Drug Administration today expanded the approval of Xeljanz (tofacitinib) to include adults with moderately to severely active ulcerative colitis. Xeljanz is the first oral medication approved for chronic use in this indication.

30 May 2018

Researchers reveal potent new mechanism of action for treatment of IBD

Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.

25 May 2018

Celltrion Healthcare advocates early introduction of biologics for patients to improve clinical outcomes

At the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes.

22 May 2018

Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Strawberries could mitigate colonic inflammation

Understanding How Antibodies Shape the Gut Microbiome

Researchers discover new protein that controls level of inflammation-inducing molecule

Long-lasting HIV control without antiretroviral therapy is a feasible goal, says expert

Scientists find key link between viruses and inflammatory bowel diseases

Study demonstrates new therapeutic targets for inflammation-associated colon cancer

Scientists pinpoint new therapeutic targets for inflammation-associated colon cancer

Study offers new hope for people with disabling Dupuytren's disease

Key innovations awards recognize PENTAX Medical for new product developments

Researchers discover immune cells that create and sustain chronic inflammatory bowel disease

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Faeces donors do it out of willingness not money - study

Cedars-Sinai study identifies gut gas associated with diarrhea

Novel PET imaging shows promise for noninvasively detecting inflammation in people with IBD

Study: People taking immunosuppressant drugs less likely to develop Parkinson's disease

Researchers trigger natural defense mechanism to alleviate intestinal inflammation

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

Researchers reveal potent new mechanism of action for treatment of IBD

Celltrion Healthcare advocates early introduction of biologics for patients to improve clinical outcomes

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in